| (BRL) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.33B | — |
| Operating expense | — | — |
| Net income | 1.10B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VRTX34.SA returned +34.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +13.5% |
| 1 year | +34.6% |
| 5 years | +173.7% |
| All-time high | R$89.57 (Apr 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what R$1,000 in VRTX34.SA would be worth today ›No. Vertex Pharmaceuticals Incorporated has not paid a dividend in the past 12 months.
Vertex Pharmaceuticals Incorporated is part of the Healthcare sector.
Vertex Pharmaceuticals Incorporated has a market cap of 720.48B BRL, based on the latest quote.
